Cutting-edge cancer treatments: expense & expectation? CRUK, 23 February, 2012

Aim of the workshop – For delegates to understand the cost/benefits of new (and existing) technologies and treatments for cancer patients the public expectations of the NHS in providing cancer treatments and the importance of PPI in cancer research and services.


Impact of the workshop –For delegates to apply in their PPI work,an informed patient perspective on the costs/benefits of new (and existing) technologies and treatments for cancer patients in the current economic climate.



Introduction and clarification of aims of the workshop

Richard Stephens, Incoming  Chair of CLG & ICPV Member


What do cancer patients want from the  NHS? - Laura Thomas, Ipsos MORI


Stratified medicine –  What is it and could it reduce costs in long term?

Dr Emily Shaw, Clinical Lead, Stratified Medicine Unit, Cancer Research UK


What is the role of chemoprevention &  do we need to licence drugs for this use? What is the future for use of orphan  drugs?

Professor Jack Cuzick, Wolfson Institute


Imaging in research and early drug  development – role of ECMC What happened to the “Star Wand?”

Prof Kerry Chester UCL , Professor of Molecular Medicine, University College London


Supporting research, protecting patients: Cancer Research UK's recommendations to reform the Clinical Trials Directive (for report on the reform go to our resources page

Emma Greenwood, Policy Manager, CRUK


Delivering World  Class Radiotherapy

Tim Cooper, Associate Director-Radiotherapy, National Cancer Action Team


New models of radiotherapy

Dr Jayant Vaidya,  Breast Cancer Specialist, University College London


How do we achieve cost effective cancer treatments in the UK?

Prof Peter Littlejohns Kings College London & previously at NICE


Drug pricing issues - Rob Day, Head of Oncololgy, Pfizer


Relationships between the pharma industry and patients - Stuart Pritchard, GSK


Click here for speakers presentations, review of the day and images



AllTrials logo


ICPV Brighton Summer School Aug 2019

ICPV was once again hosted by SHORE-C at the University of Sussex. Click here for more info.

San Antonio Breast Cancer Symposium, 2018

ICPV member Pat Fairbrother attended this event on an Alamo Foundation Scholarship. Click here to read her review.

Gap Analysis in Breast Surgery Published

The 2013 Breast Cancer Campaign gap analysis established breast cancer research priorities without a specific focus on surgical research or the role of surgeons on breast cancer research. This Review aims to identify opportunities and priorities for research in breast surgery to complement the 2013 gap analysis. Click here for more information

ICPV Review 2018
We have at last published a new edition of our review. This was achieved by a grant from Novartis. Click here for more information. 

Award for ICPV Member

Many congratulations to ICPV member Margaret Grayson. On 21 April 2018 she received the Iris Colvin Lifetime Achievement Award for Health, presented by the Women’s Forum of Northern Ireland. This is very well deserved for her tireless work in furthering cancer research especially in Northern Ireland.

Warwick Clinical Trials Course
12 members of ICPV attended a residential Clinical Trials Course at the University of Warwick from 17th to 19th April 2018. The course was run by Professor Janet Dunn and covered the different types of studies undertaken; consent; trial design; statistics and bringing a drug to market. One of the highlights of the course was a visit to the West Midlands Surgical Training Centre where delegates had the privilege of seeing real body parts and having basic anatomy explained to them by the team. The delegates would like to thank Professor Janet Dunn for her outstanding enthusiasm and for her generous hospitality.

Open letter calling on Government to prioritise interests of cancer patients in Brexit negotiations

ICPV have come together with 18 other cancer charities to put our names to an open letter to Government. We want Government to prioritise seeking continued alignment with the EU drug licensing process and Clinical Trials Regulation after Brexit. It is hoped this letter will be published in the national press in the near future.
See below to read.

Open Letter to Government
ACMC EMA letter_FINAL v2.pdf
Adobe Acrobat document [363.5 KB]

2017 Summer School

The 2017 ICPV Summer School was held over two days in June at Stirling University. The theme of the event was Cancer Survivorship and Living Well Cancer. Click below for details of the course. More details.

VOICE 2016

A snapsot video of the the 2016 course is now available on YouTube VOICE2016

eCancer Videos

At the BACR/ECMC conference in July Maggie Wilcox and Mairead Mackenzie were persuaded to speak to the camera. Maggie gave a background to ICPV and our aims and objectives. While Mairead focused on her specific interests and activities. To view follow the links below.

Maggie Wilcox

Mairead MacKenzie

Contact us by email



Or use our online contact form